ASTEC vs NACLIND: Stock Comparison
NACL Industries Limited is the larger company by market capitalisation. Astec LifeSciences Limited shows a lower P/E, while NACL Industries Limited shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ASTEC leads 2; NACLIND leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ASTEC | NACLIND |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Pesticides & Agrochemicals | Pesticides & Agrochemicals |
Price
| Metric | ASTEC | NACLIND |
|---|---|---|
| Live Price | ₹597.25 | ₹181.65 |
| Day Change | 0.77% | 3.2% |
| Volume | 21,963 | 10.02 L |
| 52-Week High | ₹941.75 | ₹245 |
| 52-Week Low | ₹513.4 | ₹112.62 |
| Distance from 52W High | -36.58% | -25.86% |
Valuation
| Metric | ASTEC | NACLIND |
|---|---|---|
| Market Cap | ₹1,341 Cr | ₹4,252 Cr |
| P/E Ratio | -20.22x | 334.91x |
| P/B Ratio | 3.45x | 6.09x |
| EPS | ₹-29.31 | ₹0.2 |
| Book Value | ₹175.3 | ₹29.16 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ASTEC | NACLIND |
|---|---|---|
| Revenue Growth (TTM YoY) | 32.7% | 79.2% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 32.7% | 79.2% |
| Qtr Profit Growth | 51.8% | 98.9% |
Profitability & Leverage
| Metric | ASTEC | NACLIND |
|---|---|---|
| ROE | -25.2% | 3.07% |
| ROCE | -5.45% | 8.08% |
| Net Margin | -14.69% | 0.29% |
| Operating Margin | -1.01% | 6.48% |
| Debt to Equity | 1.15x | 0.46x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ASTEC | NACLIND |
|---|---|---|
| Promoter Holding | 71.96%▼ 0.01 pp | 53.69%▼ 0.01 pp |
| FII Holding | 0.01%▼ 0.01 pp | 0.09%▲ 0.04 pp |
| DII Holding | 3.33%▼ 0.01 pp | 1.32%▼ 0.14 pp |
| Public Holding | 24.69%▲ 0.02 pp | 44.9%▲ 0.11 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Astec LifeSciences Limited and NACL Industries Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.